AzTrials
AzTrials

Muscle Disuse AtrophyNCT03559452

Muscle Damage and Disuse Atrophy

A study testing Eccentric exercise in people with Muscle Disuse Atrophy, run by University of Exeter at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Limb injury generally requires a period of recovery during which time the limb is often immobilised (e.g. with a cast or brace) resulting in a rapid loss of skeletal muscle. Despite the importance of muscle loss during injury, our understanding of how it occurs is incomplete. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Muscle Disuse Atrophy
What is being tested?
Eccentric exercise
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
22 participants
Where
1 siteUnited Kingdom
Study dates
1 May 2018to 31 Oct 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Aged 18 - 40
  • BMI between 18 and 27
  • Healthy, recreationally active, non smoker

Who cannot join

  • Non-removable metallic implants (including heart pacemaker, cochlear implants, medication pumps, surgical clips, plates or screws) or claustrophobia
  • Use of nutritional supplements
  • Chronic use of over the counter medication
  • Any diagnosed metabolic disease (e.g. type 1 or 2 Diabetes).
  • Any diagnosed cardiovascular disease or hypertension.
  • Anyone with previous motor disorders. Anyone with a current musculoskeletal injury that may impair their use of crutches.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • University of Exeter

    Exeter, Devon, EX1 2LU

Other trials in United Kingdom

About this study

Official title: In Young Healthy Males and Females, What is the Effect of Prior Eccentric Exercise on Thigh Muscle Atrophy During One Week of Leg Disuse Compared to no Prior Exercise?

Limb injury generally requires a period of recovery during which time the limb is often immobilised (e.g. with a cast or brace) resulting in a rapid loss of skeletal muscle. Despite the importance of muscle loss during injury, our understanding of how it occurs is incomplete. Several factors are likely to contribute, including a lack of muscle contraction and injury induced inflammation. In this study, the investigators will recruit healthy volunteers who will spend 7 days in a knee brace to replicate leg immobilisation. Prior to immobilisation, half of the participants will perform a single session of strenuous resistance exercise which is known to cause muscle damage and initiate an inflammatory response. This is designed to replicate the muscle damage and inflammation that occurs with injury. The remaining half of participants will not perform this exercise, allowing us to look at the additive effect of muscle damage and inflammation on muscle loss with immobilisation.

Being tested
Eccentric exercise
Keywords
Muscle damage, Inflammation, Immobilisation
Medical subject headings
Muscular Disorders, Atrophic, Inflammation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Eccentric exerciseProcedure or surgery

    300 eccentric contractions of the knee extensors

Study groups in NCT03559452
Study groupRoleWhat they receive
ControlNo interventionImmobilisation without prior exercise
Muscle damageExperimental300 bilateral knee extensor eccentric contraction performed immediately prior to immobilisation
Receives: Procedure: Eccentric exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in thigh muscle volume from pre-immobilisation

    The volume of the muscles comprising the thigh after 2 days of immobilisation will be compared to pre-immobilisation values. This will be measured using MRI.

    Measured: After 2 days of immobilisation

  2. Change in thigh muscle volume from pre-immobilisation

    The volume of the muscles comprising the thigh after 7 days of immobilisation will be compared to pre-immobilisation values, and values obtained after 2 days of immobilisation. This will be measured using MRI.

    Measured: After 7 days of immobilisation

Secondary outcomes (7)
  1. Change in unilateral knee extensor 1 repetition maximum

    Unilateral knee extensor 1 repetition maximum will be measured before and after 7 days of single leg immobilisation using a weight stack leg extension machine

    Measured: After 7 days of immobilisation

  2. Change in unilateral knee extensor maximal voluntary torque production

    Unilateral knee extensor maximal voluntary torque production will be measured before and after 7 days of single leg immobilisation using an isokinetic dynamometer.

    Measured: After 7 days of immobilisation

  3. Change in unilateral knee extensor isokinetic total work

    Unilateral knee extensor total isokinetic work after 30 consecutive contractions will be measured before and after 7 days of single leg immobilisation using an isokinetic dynamometer.

    Measured: After 7 days of immobilisation

  4. Muscle protein synthesis assessed using the stable isotope Deuterium Oxide

    The enrichment of deuterated alanine (from the deuterium oxide heavy water stable isotope tracer) in vastus lateralis biopsy samples will be measured relative to the non-deuterated alanine. The change between pre-immobilisation and 2 days of immobilisation will be used to calculated a fractional synthetic rate (% day).

    Measured: After 2 days of immobilisation

  5. Muscle protein synthesis assessed using the stable isotope Deuterium Oxide

    The enrichment of deuterated alanine (from the deuterium oxide heavy water stable isotope tracer) in vastus lateralis biopsy samples will be measured relative to the non-deuterated alanine. The change between pre-immobilisation and 7 days of immobilisation will be used to calculated a fractional synthetic rate (% day).

    Measured: After 7 days of immobilisation

  6. Change in skeletal muscle gene expression

    Skeletal muscle gene expression will be measured before and after 2 days of single leg immobilisation.

    Measured: After 2 days of immobilisation

  7. Change in skeletal muscle gene expression

    Skeletal muscle gene expression will be measured before and after 7 days of single leg immobilisation.

    Measured: After 7 days of immobilisation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jun 2018
  2. Study start1 May 2018
  3. Primary completion31 Oct 2019
  4. Study completion31 Oct 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
22 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03559452
Sponsor's protocol ID
171206/B/08
Status last verified
Sep 2021
First submitted
31 May 2018
Last updated
27 Sep 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Eccentric exercise in people with Muscle Disuse Atrophy, run by University of Exeter at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in thigh muscle volume from pre-immobilisation (time frame: After 2 days of immobilisation). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Sep 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in